Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma

Veterinary Pathology

Volumn 42, Issue 5, 2005, Pages 618-632

  Dickerson, E B ^a,g   Thomas, R ^b   Fosmire, S P ^c   Lamerato Kozicki, A R ^c   Bianco, S R ^c,h   Wojcieszyn, J W ^d   Breen, M ^b   Helfand, S C ^a,e   Modiano, J F ^c,f  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d IHC Services   (United States)

^e UNIVERSITY OF WISCONSIN   (United States)

^f UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^g GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^h Animal Hospital Center   (United States)

Author keywords

Canine; Endothelial cells; Hemangiosarcoma; Mutations; PTEN; Tumor progression

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

AMINO ACID SEQUENCE; ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; CELL LINE; CHEMISTRY; DOG; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; MOLECULAR GENETICS; MUTATION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMANGIOSARCOMA; MOLECULAR SEQUENCE DATA; MUTATION; PTEN PHOSPHOHYDROLASE; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 24644509362     PISSN: 03009858     EISSN: 03009858     Source Type: Journal    
DOI: 10.1354/vp.42-5-618     Document Type: Article

References (46)

1. Akhtar N, Padilla M, Dickerson E, Steinberg H, Breen M, Auerbach R, Helfand S: Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia 6:106-116, 2004
2. Besson A, Assoian RK, Roberts JM: Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat Rev Cancer 4:948-955, 2004
3. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM: p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18:862-876, 2004
4. Bloom J, Pagano M: Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin Cancer Biol 13:41-47, 2003
5. Brown NO, Patnaik AK, MacEwen EG: Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186:56-58, 1985
6. Cantley L, Neel B: New insights into tumour suppression: PTEN suppresses tumour formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245, 1999
7. Cardone M, Roy N, Stennicke H, Salvesen G, Franke T, Stanbridge E, Frisch S, Reed J: Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321, 1998
8. Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W: PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Oncogene 21:5289-5300, 2002
9. Clark AS, West K, Streicher S, Dennis PA: Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 1:707-717, 2002
10. Clifford CA, Mackin AJ, Henry CJ: Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14:479-485, 2000
11. Dahia P, FitzGerald M, Zhang X, Marsh D, Zheng Z, Pietsch T, von Deimling A, Haluska F, Haber D, Eng C: A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16:2403-2406, 1998
12. Das S, Dixon J, Cho W: Membrane-binding and activation mechanism of PTEN. Proc Natl Acad Sci USA 100:7491-7496, 2003
13. Datta S, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg M: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241, 1997
14. Fan Y, Borowsky AD, Weiss RH: An antisense oligodeoxynucleotide to p21(Waf1/Cip1) causes apoptosis in human breast cancer cells. Mol Cancer Ther 2:773-782, 2003
15. Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM, Wojcieszyn J, Breen M, Helfand SC, Modiano JF: Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Invest 84:562-572, 2004
16. Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D, Modiano JF: Nicotine activates NFATc2 and prevents cell cycle entry in T cells. J Pharmacol Exp Ther 311:758-769, 2004
17. Georgescu M, Kirsch K, Kaloudis P, Yang H, Pavletich N, Hanafusa H: Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60:7033-7038, 2000
18. Gerber H, McMurtrey A, Kowalski J, Yan M, Keyt B, Dixit V, Ferrara N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273:30336-30343, 1998
19. Gesbert F, Sellers W, Signoretti S, Loda M, JD G: BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway. J Biol Chem 275:39223-39230, 2000
20. Giri D, Ittmann M: Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum Pathol 30:419-424, 1999
21. Jiang BH, Aoki M, Zheng JZ, Li J, Vogt PK: Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad Sci USA 96:2077-2081, 1999
22. Jiang BH, Zheng JZ, Aoki M, Vogt PK: Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97:1749-1753, 2000
23. Koenig A, Bianco SR, Fosmire S, Wojcieszyn J, Modiano JF: Expression and significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma. Vet Pathol 39:458-472, 2002
24. Koul D, Shen R, Garyali A, Ke L, Liu T, Yung W: MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol 21:469-475, 2002
25. Lee HY, Srinivas H, Xia D, Lu Y, Superty R, LaPushin R, Gomez-Manzano C, Gal AM, Walsh GL, Force T, Ueki K, Mills GB, Kurie JM: Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent pathways cooperate to maintain lung cancer cell survival. J Biol Chem 278:23630-23638, 2003
26. Lee J, Yang H, Georgescu M, Di Cristofano A, Maehama T, Shi Y, Dixon J, Pandolfi P, Pavletich N: Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99:323-334, 1999
27. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM: PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8:1153-1160, 2002
28. Lim MA, Yang L, Zheng Y, Wu H, Dong LQ, Liu F: Roles of PDK-1 and PKN in regulating cell migration and cortical actin formation of PTEN-knockout cells. Oncogene 23:9348-9358, 2004
29. Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB: The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18:7034-7045, 1999
30. Maehama T, Dixon J: The tumor suppressor PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 273:13375-13378, 1998
31. Maehama T, Taylor G, Dixon J: PTEN and myotubularin: novel phosphoinositide phosphatases. Ann Rev Biochem 70:247-259, 2001
32. Modiano JF, Mayor J, Ball C, Fuentes MK, Linthicum DS: Cdk4 expression and activity are required for cytokine responsiveness in T cells. J Immunol 165:6693-6702, 2000
33. Myers M, Pass I, Batty I, Van der Kaay J, Stolarov J, Hemmings B, Wigler M, Downes C, Tonks N: The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci USA 95:13513-13518, 1998
34. Raftopoulou M, Etienne-Manneville S, Self A, Nicholls S, Hall A: Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303:1179-1181, 2004
35. Ritt MG, Mayor J, Wojcieszyn J, Smith R, Barton CL, Modiano JF: Sustained nuclear localization of p21/WAF-1 upon growth arrest induced by contact inhibition. Cancer Lett 158:73-84, 2000
36. Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL: PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8:1145-1152, 2002
37. Sorenmo K, Duda L, Barber L, Cronin K, Sammarco C, Usborne A, Goldschmidt M, Shofer F: Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J Vet Intern Med 14:395-398, 2000
38. Spangler WL, Culbertson MR: Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985-1989). J Am Vet Med Assoc 200:829-834, 1992
39. Sulis ML, Parsons R: PTEN: from pathology to biology. Trends Cell Biol 13:478-483, 2003
40. Teng D, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen K, Vinson V, Gumpper K, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford L, Lee J, Mills G, Pershouse M, Pollack R, Tornos C, Troncoso P, Yung W, Fujii G, Berson A, Steck P: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221-5225, 1997
41. Torres J, Pulido R: The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 276:993-998, 2001
42. Vazquez F, Grossman S, Takahashi Y, Rokas M, Nakamura N, Sellers W: Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276:48627-48630, 2001
43. Vazquez F, Ramaswamy S, Nakamura N, Sellers W: Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20:5010-5018, 2000
44. Vazquez F, Sellers W: The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470:M21-35, 2000
45. Wang D, Huang H, Kazlauskas A, Cavene W: Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res 59:1464-1472, 1999
46. Weng L, Brown J, Eng C: PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet 10:237-242, 2001